← Other psychedelics

4-AcO-DMT

4-Acetoxy-N,N-dimethyltryptamine

A psilocin-related psychedelic with far more reports than clinical evidence.

C₁₄H₁₈N₂O₂View molecular structure

4-AcO-DMT, also called psilacetin, is a synthetic tryptamine closely related to psilocin. It is often discussed alongside psilocybin because the compounds share a metabolic connection.

That relationship is useful context, but it does not make mushroom research directly interchangeable with evidence about 4-AcO-DMT.

4-AcO-DMT at a glance

Family
Tryptamines
Type
Serotonergic psychedelic
Primary target
5-HT2A; psilocin-related activity
Onset (oral)
Not well established in trials
Duration (oral)
Several hours; limited human data
Origin
Synthetic

What is 4-AcO-DMT?

4-AcO-DMT is the acetylated form of psilocin. Laboratory metabolism studies support conversion into psilocin, although its complete activity and time course in humans are not well characterised.

Calling it a psilocin prodrug describes a proposed metabolic role. It does not prove that all its effects, risks or absorption match those of psilocybin.

The 4-AcO-DMT experience

Sensory effects

Firsthand accounts often describe shifting patterns and dreamlike imagery, with frequent comparisons to psilocybin. Controlled comparisons remain scarce.

Changes in music and sound appear in some reports, but there is too little systematic evidence to describe a reliable auditory profile.

Body sensations

Reports include altered bodily sensations, nausea and physical discomfort. Uncertain product identity and limited human research make generalisations difficult.

Headspace

Emotional amplification, introspection and unusual associations recur in accounts. Some people describe connection; others describe anxiety or confusing thought loops. These are reported themes, not predictions.

Self, time and space

Accounts sometimes describe altered time and a less familiar sense of self. The depth and character of these changes are not well established in controlled studies, and mushroom experiences cannot simply be assumed to apply.

History and culture

4-AcO-DMT emerged from twentieth-century tryptamine chemistry and later became known in online psychonaut communities. Its cultural history differs from the long ceremonial histories of mushroom use.

The name psilacetin is sometimes used to distinguish the compound from DMT and other similarly named tryptamines.

Research and uses

Published work includes metabolism and receptor-related studies. There is much less controlled human evidence than for psilocybin.

Its relationship to psilocin makes it scientifically interesting, but therapeutic claims need direct testing. Benefits demonstrated with another compound and clinical protocol cannot simply be transferred to it.

Risks and considerations

Limited evidence leaves uncertainty about short- and long-term risks. Intense distress, impaired judgement and physical adverse effects remain possible.

Unregulated products may contain different compounds or concentrations from those claimed. Sparse research should be read as uncertainty, rather than reassurance.

FAQ

Is it a mushroom extract?

No. 4-AcO-DMT is generally described as a synthetic compound, not ordinary psilocybin mushroom extract.

Is it identical to psilocybin?

No. Both are related to psilocin, but their chemical structures differ.

Why are the timing facts less precise?

Controlled human evidence is limited. Precise-looking ranges would imply more certainty than the evidence supports.

Sources
  1. 4-AcO-DMT metabolism study
  2. NIH: Psychedelic and dissociative drugs
  3. PubChem: 4-AcO-DMT molecular identity